Metabolic syndrome in type-2 diabetics: an update on the silent epidemic

被引:0
|
作者
Tariq, Mohammad [1 ]
Hadi, Abdul [1 ]
Rahman, Sadeeq Ur [1 ]
机构
[1] Med B Ward Khyber Teaching Hosp, Dept Med, Peshawar, Pakistan
来源
RAWAL MEDICAL JOURNAL | 2010年 / 35卷 / 02期
关键词
Metabolic syndrome; Type-2; diabetes; obesity; hyperlipidemia;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine frequency of metabolic syndrome in patients with type-2 diabetes. Methods This was a cross sectional study was conducted in Khyber Teaching Hospital, Peshawar and during an eight months period, 200 adult type-2 diabetics were evaluated for the presence of metabolic syndrome. ATP-III criteria was used for its frequency. Result Of 200 patients, 154 (77%) had metabolic syndrome. Out of these154 patients, 92 (59.7) were female and 62 (40.2%) were male. Ninety seven (62.98%) patients were between the age group 41 to 60 years. In 68 (44.15%) patients, all the five risk factors for the metabolic syndrome were present. However, in 57 (37.01%) patients only 3 risk factors were present. Abdominal obesity was present in 80 (51.94%) female and in 43 (27.92%) male patients. However, 68 (44.15%) female and 49 (31.81%) males had low HDL levels. Fifty six (36.36%) females and 41 (26.62%) males had elevated levels of triglycerides. Hypertension was present in 82 (53.24%) females and 48 (31.16%) males. Conclusion This study showed a very high prevalence of the metabolic syndrome in type 2 diabetic population. Females were more affected than males in all respects.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Smoking and metabolic syndrome of type 2 diabetics
    Marmouch, H.
    Baba, A.
    Khochtali, I.
    Hamza, N.
    Mahjoub, S.
    DIABETES & METABOLISM, 2010, 36 : A92 - A93
  • [2] PHARMACOKINETICS AND METABOLIC EFFECTS OF GLIBENCLAMIDE AND GLIPIZIDE IN TYPE-2 DIABETICS
    GROOP, L
    WAHLINBOLL, E
    GROOP, PH
    TOTTERMAN, KJ
    MELANDER, A
    TOLPPANEN, EM
    FYHRQVIST, F
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (06) : 697 - 704
  • [3] Depression in type 2 diabetics with and without metabolic syndrome
    Marmouch, H.
    Hasni, Y.
    Cherif, Y.
    Siala, L.
    Mahjoub, S.
    DIABETES & METABOLISM, 2012, 38 : A93 - A93
  • [4] Inflammatory parameters in type 2 diabetics and in the metabolic syndrome
    Grosz, A.
    Nagy, E.
    Halmos, T.
    DIABETOLOGIA, 2006, 49 : 445 - 445
  • [5] ENZYMATIC, METABOLIC AND SECRETORY PATTERNS IN HUMAN ISLETS OF TYPE-2 DIABETICS
    FERNANDEZALVAREZ, J
    CONGET, I
    SENER, A
    GOMIS, R
    MALAISSE, WJ
    DIABETOLOGIA, 1993, 36 : A103 - A103
  • [6] New insights on metabolic syndrome: A "silent" but visible epidemic
    Donahue, Philip E.
    ANNALS OF SURGERY, 2008, 247 (06) : 916 - 917
  • [7] HEPATIC FUTILE CYCLE IS AN IMPORTANT METABOLIC PATHWAY IN LEAN TYPE-2 DIABETICS
    EFENDIC, S
    WAJNGOT, A
    VRANIC, M
    DIABETES, 1983, 32 : A72 - A72
  • [8] Metabolic syndrome and cardiovascolar autonomic function in type 2 diabetics
    Garruti, G.
    Vita, M. G.
    Giampetruzzi, F.
    Pellegrino, F.
    Mallardi, G.
    Lagioia, P.
    Giorgino, F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 : 44 - 44
  • [9] A COMPARISON OF THE METABOLIC PROFILES IN TYPE-2 DIABETICS DURING GLIPIZIDE AND GLIBENCLAMIDE TREATMENT
    TAYLOR, R
    ISLES, TE
    MCLAREN, S
    NEWTON, RW
    DIABETOLOGIA, 1981, 21 (03) : 335 - 335
  • [10] Prevention of microalbuminuria in type-2 diabetics
    Nitschmann, S
    INTERNIST, 2006, 47 (02): : 199 - 200